[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Clinical Challenges in Otolaryngology
March 2003

The Use of Genetic Markers in the Clinical Care of Patients With Head and Neck Cancer

Author Affiliations
 

KAREN H.CALHOUNMD

 

RONALD B.KUPPERSMITHMD

Arch Otolaryngol Head Neck Surg. 2003;129(3):363-366. doi:10.1001/archotol.129.3.363

Hypothesis: Genetic markers are not currently useful in the clinical care of patients with head and neck cancer.

During the past few years, there has been an explosion in the number of articles investigating genetic markers and head and neck cancer. This is interesting for the scientist but confusing for the clinician. It is difficult to decipher the utility of the "alphabet soup" of molecular markers found in the literature. The genes described are unfamiliar to most otolaryngologists treating patients with head and neck cancer, and the articles are confounded by conflicting data.

First Page Preview View Large
First page PDF preview
First page PDF preview
×